Results 241 to 250 of about 762,836 (292)

Development of Water-Trapping Pyrrole-2-carboxylic Acids as Broad-Spectrum Metallo-β-lactamase Inhibitors. [PDF]

J Med Chem
Singha M, Wilson LA, C M Moura EC, Trush MM, Calvopina K, Kaur G, Zaborskytė G, Kalniņš T, Panduwawala T, Bowen MJ, Beech MJ, Brem J, McHugh PJ, Suna E, Walsh TR, Schofield CJ, Farley AJM.   +16 more
europepmc   +1 more source

Design, Synthesis, and Evaluation of β‑Lactamase Inhibitors as Potential Therapeutics for Antimicrobial Resistance. [PDF]

ACS Omega
Batool S, Farid R, Azam SS, Hassan A.
europepmc   +1 more source

Etymologia: β-Lactamase

Emerging Infectious Diseases, 2016
doaj   +1 more source

Differences in β-lactamase activity and carbapenem resistance among the <i>Bacillus cereus</i> group. [PDF]

Antimicrob Agents Chemother
Nishihara Y, Nakano R, Nakano A, Suzuki Y, Ogawa M, Sakata R, Yano H, Kasahara K.   +7 more
europepmc   +1 more source

Evidence of intrapulmonary penetration of nacubactam, a novel β-lactamase inhibitor, following coadministration of nacubactam with meropenem in healthy adults. [PDF]

Antimicrob Agents Chemother
Morita J, Ishiwata K, Matsumoto S, Kato S, Attley G, Patel K, Rodriguez I, Mallalieu NL.   +7 more
europepmc   +1 more source

Management of metallo-β-lactamase-producing Enterobacterales infections: a modified Delphi study. [PDF]

JAC Antimicrob Resist
Carmeli Y, Price M, Daikos GL, Falcone M, Gales AC, Hagel S, Omrani AS, Ramirez P, Todi S, Wang M, Gheorghe M, Hauber B, Little CJ, Townsend A.   +13 more
europepmc   +1 more source

Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infection. [PDF]

JAC Antimicrob Resist
Morita J, Ishiwata K, Matsumoto S, Kato S, Attley G, Patel K, Rodriguez I, Mallalieu N.   +7 more
europepmc   +1 more source

Binding mode of Isoxazolyl Penicillins to a Class-A β-lactamase at ambient conditions. [PDF]

Commun Chem
Gore G, Prester A, von Stetten D, Bartels K, Schulz EC.   +4 more
europepmc   +1 more source

Data-driven design and screening of novel <i>Klebsiella pneumoniae</i> carbapenemase-2 β-lactamase inhibitors using a generative CLM. [PDF]

RSC Adv
Tariq SS, Haleem MS, Uddin R.
europepmc   +1 more source